Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Nrt Smoking Cessation Aids in Australia

Published by: Euromonitor International

Published: May. 9, 2009 - 67 Pages


Table of Contents


Nrt Smoking Cessation Aids in Australia
Euromonitor International
May 2009
Executive Summary
OTC Healthcare Continues To Grow Steadily
Symbion Health Ltd Undergoes Multiple Acquisitions
Symbion Health Ltd Retains Lead in OTC Healthcare
Retail Pressure Heat Up As Grocery Retailers Continue To Strengthen
Moderate Growth Expected Over Forecast Period
Key Trends and Developments
Convenience Featuring Highly in Both Product Development and Distribution
Preference for Branded Products Over Generics and Private Label
Child-specific Products Experience Growth
Negative Publicity Associated With Side Effects of OTC Healthcare
Rising Retail Pressures for Chemists/pharmacies
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Market Data
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2008
Definitions
Summary 2 Research Sources
Ego Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 3 Ego Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Ego Pharmaceuticals Pty Ltd: Competitive Position 2008
Herron Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 5 Herron Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 6 Herron Pharmaceuticals Pty Ltd: Competitive Position 2008
Inova Pharmaceuticals (australia) Pty Ltd
Strategic Direction
Key Facts
Summary 7 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
Company Background
Production
Summary 8 iNova Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2008
Competitive Positioning
Summary 9 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive Position 2008
Pharmacare Laboratories Pty Ltd
Strategic Direction
Key Facts
Summary 10 Pharmacare Laboratories Pty Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 11 Pharmacare Laboratories Pty Ltd: Competitive Position 2008
Symbion Health Ltd
Strategic Direction
Key Facts
Summary 12 Symbion Health Ltd: Key Facts
Summary 13 Symbion Health Ltd: Operational Indicators
Company Background
Production
Summary 14 Symbion Health Ltd: Production Statistics 2008
Competitive Positioning
Summary 15 Symbion Health Ltd: Competitive Position 2008
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Indicators
Table 12 Number of Smokers by Gender 2003-2008
Sector Data
Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 15 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 16 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 17 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 19 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013

Abstract

Euromonitor International's NRT Smoking Cessation Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?
  • Get a detailed picture of the smoking cessation aids industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market’s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009